Does Medicaid cover Mounjaro in California?

If you’re exploring weight loss medications like Wegovy, Ozempic, or Mounjaro, you’ve likely asked yourself one crucial question: Will my insurance actually cover this? The answer is complicated—and often frustrating. While these GLP-1 medications have transformed weight management and metabolic health, navigating insurance coverage feels like decoding a different language entirely.

The reality is that most insurance plans treat weight loss drugs very differently than they treat diabetes medications—even when it’s the same drug. Understanding what’s covered, what requires prior authorization, and what you’ll pay out-of-pocket can mean the difference between affordable treatment and spending over $1,000 per month.

In this guide, we’ll break down exactly how insurance covers (or doesn’t cover) the most popular GLP-1 medications, what criteria you need to meet, how to appeal denials, and what to do if your plan won’t pay.

The Big Picture: Why Weight Loss Drug Coverage Is So Complicated

Here’s the fundamental issue: Insurance companies don’t have to cover weight loss medications. Unlike diabetes drugs, which are considered essential, anti-obesity medications are often classified as ‘lifestyle’ treatments—optional benefits that employers and insurers can choose to exclude.

According to data from the Kaiser Family Foundation, only about 13 states mandate Medicaid coverage for obesity drugs, and even then, strict criteria apply. Most commercial insurance plans either exclude weight loss medications outright or impose significant barriers like high copays, prior authorization requirements, and step therapy protocols.

Why the Resistance?

The answer is cost. GLP-1 medications carry list prices exceeding $1,000 per month. With millions of Americans living with obesity, insurers worry about unsustainable spending. A 2024 analysis found that if all eligible Medicaid recipients used these drugs, costs could exceed billions annually—money that state budgets and private insurers argue they simply don’t have.

But here’s what makes this especially challenging: the same medication gets covered or denied based purely on why it’s prescribed. Ozempic for Type 2 diabetes? Usually covered. Ozempic for weight loss? Almost always denied. Wegovy (which is literally the same active ingredient as Ozempic, just FDA-approved for obesity)? Tightly restricted or excluded entirely.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Wegovy, Ozempic, and Mounjaro: What Does Insurance Actually Cover?

Let’s break down coverage by medication and insurance type.

Wegovy (Semaglutide for Weight Loss)

Commercial Insurance: Coverage is limited and highly variable. Many employer-sponsored plans exclude Wegovy entirely as a cost-saving measure. Plans that do cover it typically require:

• BMI of 30 or higher (or 27+ with weight-related conditions like hypertension or sleep apnea)
• Documentation of at least 6 months of supervised diet and lifestyle modification attempts
• Prior authorization demonstrating medical necessity
• Sometimes, evidence that you’ve tried and failed with older, cheaper weight loss medications

Even with approval, Wegovy is usually placed in Tier 3 or Tier 4 (specialty tier), meaning high copays—often $100 to $300+ per month even with insurance.

Medicare Part D: Here’s the catch—Medicare does not cover drugs prescribed solely for weight loss, by federal law. The only exception? If Wegovy is prescribed for an FDA-approved use other than weight management—such as reducing cardiovascular risk in obese patients with heart disease. In that narrow case, Part D plans may cover it. But if your doctor writes ‘for weight loss,’ expect a denial.

Medicaid: This is where state-by-state variation matters most. As of late 2025:

• California covered Wegovy with strict criteria through 2025, but coverage ends January 1, 2026 due to budget cuts.
• Pennsylvania offered coverage with prior authorization in 2024, but also announced it will discontinue coverage in January 2026.
• Texas and Florida do not cover weight loss medications at all under Medicaid—they’ve invoked the federal exclusion allowing states to opt out.
• New York continues to cover Wegovy with prior authorization, requiring BMI criteria and lifestyle documentation.

If you’re on Medicaid and your state doesn’t cover obesity drugs, your only option is often paying out-of-pocket or exploring manufacturer assistance programs.

Ozempic (Semaglutide for Type 2 Diabetes)

Commercial Insurance: When prescribed for Type 2 diabetes, Ozempic is widely covered as an essential diabetes treatment. Most plans include it on their formularies, though it’s typically a Tier 3 brand medication with moderate-to-high copays ($50–$150/month is common).

However, off-label use for weight loss is not covered. If you don’t have diabetes and your doctor prescribes Ozempic for obesity, your claim will likely be denied. Insurers use prior authorization systems to flag and block prescriptions that don’t align with an approved diagnosis code.

Medicare Part D: Covered for diabetes management, usually with prior authorization to confirm diagnosis and document that other first-line treatments (like metformin) were tried first. Not covered for weight loss.

Medicaid: Covered in all states for Type 2 diabetes, following standard diabetes medication policies. Off-label weight loss use is not covered.

The Bottom Line: If you have diabetes, Ozempic is accessible through insurance. If you’re using it solely for weight management, you’ll pay full price—around $900 to $1,000 per month without discounts.

Mounjaro (Tirzepatide for Type 2 Diabetes)

Commercial Insurance: Similar to Ozempic, Mounjaro is covered for Type 2 diabetes but not for obesity (that’s where Zepbound, the weight-loss version of tirzepatide, comes in—and Zepbound faces the same coverage barriers as Wegovy).

Prior authorization is almost always required. Insurers want proof that you’ve tried other diabetes medications first, unless your A1c is very high or you have specific contraindications. Mounjaro is often placed in Tier 3 or Tier 4 (specialty) due to its high cost, with typical copays ranging from $75 to $200+ per month.

Medicare Part D: Covered for diabetes with prior authorization. Not covered for weight loss.

Medicaid: Covered for diabetes in most states, subject to prior authorization and step therapy (trying cheaper medications first). Weight loss use is excluded.

The Bottom Line: Mounjaro access depends on having a diabetes diagnosis and meeting insurer criteria. For weight management alone, coverage is virtually nonexistent without special circumstances.

Understanding Prior Authorization: The Gatekeeper to Coverage

Even when your insurance technically covers a GLP-1 medication, prior authorization (PA) is almost always required. This is the process where your doctor submits clinical documentation to your insurer, proving that the medication is medically necessary.

What Do Insurers Look For?

For weight loss medications like Wegovy, typical PA requirements include:

1. BMI threshold: Usually 30 or higher (or 27+ with comorbidities like diabetes, hypertension, or obstructive sleep apnea)
2. Age requirement: Most plans require patients to be 18 or older
3. Lifestyle intervention: Documentation of at least 6 months of supervised diet and exercise programs with a healthcare provider
4. Weight-related health condition: Evidence of conditions like prediabetes, high cholesterol, or joint problems related to excess weight
5. Failure of previous treatments: Some plans require proof that you tried older weight loss medications (like phentermine or orlistat) without success

For diabetes medications like Ozempic or Mounjaro, PA criteria focus on:

• Confirmed Type 2 diabetes diagnosis (with lab results showing elevated A1c)
• Evidence of inadequate glucose control on first-line medications (usually metformin)
• Documentation of contraindications if skipping step therapy
• Sometimes, proof of cardiovascular risk factors justifying a GLP-1 over other options

How Long Does Prior Authorization Take?

Most insurers process PA requests within 5 to 7 business days. If you need the medication urgently, your doctor can request an expedited review, which may get a decision within 24–72 hours. However, if additional documentation is needed, the process can stretch to 2–3 weeks.

Pro tip: If you’re working with a telehealth provider like Klarity Health, make sure they handle prior authorization as part of their service. Klarity’s providers have experience navigating insurance requirements and can submit comprehensive PA requests on your behalf, improving your chances of approval.

Common Denial Reasons—and How to Appeal

Even when you meet criteria, denials happen. Here are the most common reasons and what to do about them:

1. Not Meeting Medical Necessity Criteria

Why it happens: Your documented BMI is below the threshold, or you lack a required comorbidity.

What to do: Request that your doctor re-submit with updated weight measurements and comprehensive documentation of all weight-related health conditions. Sometimes a letter of medical necessity emphasizing the risks of untreated obesity can make the difference.

2. Insufficient Documentation of Lifestyle Intervention

Why it happens: The insurer can’t confirm you’ve tried diet and exercise under medical supervision for 6+ months.

What to do: Gather records from your primary care provider, nutritionist visits, weight loss program enrollment, or even a detailed personal log of your efforts with timestamps. Resubmit with this evidence.

3. Step Therapy Not Met

Why it happens: The plan requires you to try cheaper alternatives first (like phentermine for obesity, or metformin for diabetes).

What to do: If you have contraindications to those medications (side effects, allergies, medical reasons they won’t work), document them. If you’ve already tried them without success, make sure that’s clearly stated in your records.

4. Off-Label Use

Why it happens: You’re prescribed Ozempic for weight loss when you don’t have diabetes.

What to do: This is tough. Your best option might be switching to Wegovy (the FDA-approved weight loss version) if your plan covers it. Otherwise, you’re looking at self-pay.

5. Plan Exclusion

Why it happens: Your employer’s plan simply doesn’t cover weight loss drugs, period.

What to do: Unfortunately, if your plan has a blanket exclusion, appeals rarely succeed. You can advocate for your employer to add this benefit during open enrollment, or explore self-pay options and manufacturer savings programs.

How to Appeal Effectively

If denied, follow these steps:

1. Read the denial letter carefully to understand the specific reason
2. Gather all supporting documentation: medical records, lab results, weight history, lifestyle program records
3. Request a letter of medical necessity from your doctor explaining why this medication is essential for your health
4. Submit a formal appeal within the timeframe specified (usually 60–180 days)
5. Follow up regularly with your insurer to track the appeal’s progress

Success rates for appeals vary, but persistence and thorough documentation significantly improve your odds—especially if the initial denial was due to missing information rather than a policy exclusion.

What If Insurance Won’t Cover It? Your Self-Pay Options

If insurance denies coverage or you’re uninsured, you’re not out of options. Recent developments in 2025 have significantly reduced self-pay costs for GLP-1 medications.

Manufacturer Discount Programs

Novo Nordisk (Wegovy & Ozempic):

• NovoCare Savings Card: If you have commercial insurance, you may qualify for copay assistance reducing your cost to as low as $0–$25 per month (covering up to $225 in copay)
• Cash-Pay Program: Through the Wegovy Access program, self-pay patients can now get Wegovy for $349 per month (down from the ~$1,350 list price)
• Patient Assistance Program: Uninsured individuals meeting income criteria can receive Wegovy at no cost

Eli Lilly (Mounjaro & Zepbound):

• Savings Card: For diabetes use, eligible patients may pay just $25/month
• LillyDirect Program: Self-pay Zepbound (weight loss version) now available in single-dose vials for $299–$449 depending on dose
• Patient Assistance Program: Free medication for qualifying low-income patients

GoodRx and Discount Programs

In November 2025, GoodRx launched a game-changing partnership with Novo Nordisk:

• Introductory pricing: $199 per month for the first two months of Wegovy or Ozempic
• Ongoing pricing: Around $349 per month after the intro period
• Availability: Works at nearly all major pharmacies nationwide

This represents a 60–70% discount off standard retail prices—making these medications far more accessible to self-paying patients.

Important note: GoodRx coupons cannot be combined with insurance. You’re choosing between using insurance (with whatever copay applies) or using the GoodRx discount as a self-pay patient.

The Compounding Pharmacy Debate

Some telehealth providers and wellness clinics offer compounded semaglutide or tirzepatide at lower prices—often $200–$400 per month. While this might sound appealing, be aware:

• Not FDA-approved: Compounded versions aren’t subject to the same quality controls as brand medications
• Safety concerns: The FDA has issued warnings about compounded GLP-1s due to reports of incorrect dosing, contamination, and adverse events
• Effectiveness unknown: There’s no guarantee that compounded formulations work as well as the FDA-approved products

If cost is your primary barrier, explore manufacturer assistance programs and GoodRx discounts before turning to compounding pharmacies.

Telehealth and Insurance: A Silver Lining

One bright spot in this complex landscape is telehealth coverage. Since the pandemic, most insurance plans—including Medicare and Medicaid—have expanded coverage for virtual healthcare visits.

How It Works

Commercial Insurance: Over 40 states now have telehealth parity laws requiring private insurers to cover virtual visits at the same rate as in-person care. This means:

• Your consultation for weight management can happen entirely online
• Copays are typically the same as office visits
• Follow-up appointments, prescription management, and ongoing support are all covered services

Medicare: Telehealth coverage expanded dramatically in 2020 and has been extended through 2025. Medicare Part B covers telehealth visits with any healthcare provider, including for weight management counseling (a preventive service).

Medicaid: All states now cover some form of telehealth under Medicaid, though specific services and reimbursement rates vary.

What This Means for You

If you’re considering a platform like Klarity Health, here’s what matters:

• Provider Network: Check if the telehealth provider is in-network with your insurance. Klarity works with major insurers and also accepts both insurance and cash pay, giving you flexibility.
• Transparent Pricing: Even if you’re paying out-of-pocket for the visit, knowing the cost upfront (which Klarity provides) helps you plan. Many patients find that telehealth visits are actually cheaper than traditional doctor copays.
• Prescription Coverage: Your insurance will still cover the medication prescription the same way it would from an in-person doctor—meaning if your plan covers Wegovy, it doesn’t matter whether the prescription came from a telehealth visit or traditional office visit.

The convenience of telehealth also means more frequent touchpoints with your provider, which can strengthen your prior authorization case (more documented visits = more proof of medical supervision and lifestyle intervention).

State-by-State Medicaid Snapshot: Where Weight Loss Medications Are Covered

If you’re on Medicaid, your location matters enormously. Here’s a quick reference for key states:

If your state doesn’t cover obesity medications, your options are:

1. Patient assistance programs (free medication if you meet income requirements)
2. Self-pay with discount programs (GoodRx, manufacturer cash-pay options)
3. Advocacy: Contact your state legislators to request expanded Medicaid coverage for evidence-based obesity treatments

Practical Steps: Getting Your Weight Loss Medication Covered

Here’s your action plan:

Step 1: Check Your Formulary

Log into your insurance portal and search for ‘Wegovy,’ ‘Ozempic,’ or ‘Mounjaro’ to see if they’re covered and what tier they’re on. Note any restrictions listed.

Step 2: Understand Your BMI and Health Status

Calculate your BMI and document any weight-related health conditions (diabetes, prediabetes, high blood pressure, sleep apnea, joint pain, etc.). These strengthen your case for medical necessity.

Step 3: Gather Documentation of Lifestyle Efforts

Compile records of diet programs, exercise plans, nutritionist visits, or medically supervised weight loss attempts from the past 6–12 months.

Step 4: Choose the Right Provider

Work with a provider experienced in obesity medicine and prior authorization. Telehealth platforms like Klarity Health specialize in weight management and have providers who understand exactly what documentation insurers need. Klarity’s transparent pricing and availability (with appointments often available within days) make it easy to get started quickly.

Step 5: Submit Prior Authorization

Your provider will submit the PA request with all supporting documentation. Stay in close contact during this process and respond quickly if the insurer requests additional information.

Step 6: Plan for Denials

If denied, don’t give up. Use the appeal process and consider resubmitting with more detailed evidence. Many denials are overturned on appeal when criteria are actually met.

Step 7: Explore All Financial Options

Even if insurance won’t cover the medication, check:

• Manufacturer savings cards (often reduce costs to $0–$25/month)
• GoodRx discount programs ($199–$349/month)
• Patient assistance programs (free medication for those who qualify)
• Alternative medications that might be better covered

The Bottom Line: Your Path Forward

Navigating insurance coverage for weight loss medications is frustrating—there’s no way around it. The system is fragmented, rules vary wildly by plan and state, and even when you meet every criterion, denials happen.

But here’s what you need to know: These medications work, they’re life-changing for many people, and access is improving. Manufacturer price cuts, new discount programs, and growing recognition of obesity as a chronic disease are slowly shifting the landscape.

If you’re ready to explore GLP-1 medications:

1. Start with your insurance—understand what’s covered and what criteria you need to meet
2. Work with experienced providers who can navigate the PA process effectively
3. Be prepared to advocate for yourself through appeals if necessary
4. Know that self-pay options are now more affordable than ever

Klarity Health offers a straightforward path forward: Our providers specialize in weight management, accept both insurance and cash pay, and are available quickly (often within days). With transparent pricing and providers who understand the complexities of insurance authorization, Klarity removes much of the guesswork from accessing GLP-1 medications.

Whether your insurance covers these treatments or you’re exploring self-pay options, you deserve clear information, supportive care, and access to evidence-based treatments that can genuinely transform your health.

Frequently Asked Questions

Q: Can I use a GoodRx coupon if I have insurance?
A: You can, but you’ll be choosing between using your insurance or the GoodRx discount—you can’t combine them. Compare your insurance copay to the GoodRx price and use whichever is lower.

Q: How long does prior authorization typically take?
A: Most insurers respond within 5–7 business days. Expedited reviews can take 24–72 hours. Appeals may take 2–4 weeks.

Q: Will my insurance cover Ozempic for weight loss if I don’t have diabetes?
A: Almost certainly not. Insurers only cover Ozempic for its FDA-approved indication (Type 2 diabetes). For weight loss, you’d need Wegovy—and even that faces coverage barriers.

Q: What if I’m on Medicare and need weight loss medication?
A: Medicare Part D doesn’t cover drugs prescribed solely for weight loss due to federal law. The exception is if the medication is prescribed for another covered condition (like cardiovascular risk reduction). Otherwise, you’ll need to pay out-of-pocket or apply for manufacturer assistance.

Q: Are there cheaper alternatives to GLP-1 medications?
A: Older weight loss medications like phentermine, orlistat (Alli/Xenical), or combination drugs (Contrave, Qsymia) are significantly cheaper ($30–$150/month) and may be covered by insurance. However, they generally aren’t as effective as GLP-1 medications. Discuss with your provider which option makes sense for your situation.

Q: Can I get Wegovy through a telehealth provider and still use insurance?
A: Yes, as long as the telehealth provider is in your insurance network or your plan covers out-of-network telehealth. The prescription itself will be processed through your pharmacy benefit the same way any prescription would be, regardless of whether it came from telehealth or an in-person visit.

📅 RESEARCH CURRENCY STATEMENT (Verified as of December 17, 2025)

Top 5 Citations:

1. California Department of Health Care Services Medi-Cal Announcement – GLP-1 Medications for Weight Loss Will No Longer Be Covered by Medi-Cal (December 2025) (www.cmadocs.org)

2. Kaiser Family Foundation Issue Brief – Medicaid Coverage of and Spending on GLP-1 Drugs (November 4, 2024) (www.kff.org)

3. GoodRx Press Release via BusinessWire – GoodRx Launches $199 Per Month Introductory Cash Price for Ozempic and Wegovy (November 17, 2025) (www.businesswire.com)

4. Fierce Pharma – Novo Unveils Newly Reduced Self-Pay Prices for Wegovy and Ozempic After White House Deal (November 2025) (www.fiercepharma.com)

5. Pennsylvania Health Law Project – Pennsylvania Medicaid Covers Newer Weight Loss Drugs (August 2024) (www.phlp.org)

Coverage status, pricing, and state policies are subject to change. Always verify current coverage with your insurance provider and check the latest formulary information before starting treatment.

Source:

• https://www.aetna.com/products/rxnonmedicare/data/2024/WeightLoss%28BMI%2035%29GIP-GLP-1GLP-1AgonistsPAwithLimit6450-CUDR_05-2024.html#:~:text=%C2%B0Wegovy%3A%20Initial%20therapy%20DOA%3A%207,based%20on%20the%20following%20references
• https://www.singlecare.com/blog/cigna-prior-authorization-weight-loss/#:~:text=Cigna%20coverage%20criteria%20for%20GLP,drugs
• https://www.amwinsconnect.com/news/kaiser-permanenter-coverage-changes-glp-1-drugs-and-anti-obesity-medications-2025#:~:text=drugs%20and%20other%20AOMs%20will,with%20BMI%20less%20than%2040
• https://www.texaschildrenshealthplan.org/2023/04/28/provider-alert-non-formulary-requests-for-obesity-control-drugs#:~:text=for%20obesity%20control%20drugs%20for,Imcivree%2C%20Qysmia%2C%20Saxenda%20and%20Wegovy
• https://www.phlp.org/en/news/pennsylvania-medicaid-covers-newer-weight-loss-drugs#:~:text=Generally%2C%20to%20get%20these%20drugs,CDC%29%20charts
• https://www.cmadocs.org/newsroom/news/view/ArticleId/51074/GLP-1-medications-for-weight-loss-will-no-longer-be-covered-by-Medi-Cal#:~:text=What%20You%20Need%20to%20Know%3A,Cal%20managed%20care
• https://solutionshortcut.com/medicaid-drug-coverage-by-state-2025-2026-updates/#:~:text=VDP%20PDL%20%26%20criteria%3B%20last,com
• https://www.cmadocs.org/newsroom/news/view/ArticleId/51074/GLP-1-medications-for-weight-loss-will-no-longer-be-covered-by-Medi-Cal#:~:text=%2A%20Three%20GLP,covered%20after%20January%201%2C%202026
• https://www.forbes.com/sites/joshuacohen/2025/08/07/coverage-of-weight-loss-drugs-by-medicaid-plans-continues-to-lag/#:~:text=Medicaid%2C%20a%20federal,employees%20due%20to%20cost%20concerns
• https://www.fiercepharma.com/marketing/novo-unveils-newly-reduced-self-pay-prices-wegovy-ozempic-after-white-house-deal#:~:text=Novo%20revealed%20Monday%20that%20the,will%20still%20run%20for%20%24499